Medical Device Daily: Med-Tech Notes - Carbylan BioSurgery, Inc.
February 06, 2013 - Medical Device Daily
Carbylan BioSurgery (Palo Alto) raised $6 million in Series C financing from InterWest Partners, Alta Partners, and Vivo Ventures. Carbylan BioSurgery develops medical devices and device/drug combination products based on chemically-engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat the pain associated with osteoarthritis. Carbylan biopolymers are biomaterials that, when combined with pharmaceutical agents, enable the development of unique medical products.